TK1 and breast cancer: Studies have shown that serum TK1 can be used as a monitoring indicator for adjuvant therapy of breast cancer, but whether it can be applied to the clinical efficacy and long-term prognosis assessment of patients with advanced breast cancer with her-2 positive remains to be further studied [10].